AVBP SCHEDULE 13D/A: SEC filing
OrbiMed entities
Filed with the SEC on · accession 0000947871-26-000931
AVBP filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Oct 8, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.1% by the first close after the filing.
Summary of the filing
OrbiMed entities filed Amendment No. 2 to their Schedule 13D regarding their ownership of ArriVent BioPharma common stock, executed via a joint filing agreement dated October 8, 2026.
Key details
How AVBP stock reacted
Close before
$16.89
Oct 7, 2026
First close after
-1.07%
$16.71
5 trading days
-4.09%
$16.20
Since filing
-19.24%
$13.64
✦ Ask GOAX AI about this filing — what it means for AVBP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVBP?
Click hereFrequently asked questions
What did AVBP file with the SEC on Oct 8, 2026?
AVBP filed a SCHEDULE 13D/A (SEC filing). OrbiMed entities filed Amendment No. 2 to their Schedule 13D regarding their ownership of ArriVent BioPharma common stock, executed via a joint filing agreement dated October 8, 2026.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did AVBP stock react to this filing?
AVBP closed at $16.89 before the filing and $16.71 on Oct 8, 2026 (-1.07%). Five trading days later: $16.20 (-4.09%).
Other AVBP SEC filings
Get alerts when AVBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days